A plaintiff and his wife have filed a Byetta cancer lawsuit in California, claiming long time use of the drug to treat type II diabetes led to a thyroid cancer diagnosis. This complaint joins a growing number of Byetta & Januvia lawsuits in coordinated proceedings in the U.S. District Court... Read more »

Another Risperdal lawsuit over gynecomastia has been filed, this time in Louisiana. Karon-Jahlil Williams v. Janssen Pharmaceuticals, Inc., Johnson & Johnson, and Janssen Research and Development, L.L.C. (Case # 5:14-cv-03354) was filed on December 2, 2014 in the US. District Court for the Western District of Louisiana (Shreveport Division). The... Read more »

When patients take a medication, they generally trust that the drug is reasonably safe and will treat their medical condition without the risk of long-term, serious side effects. When drug manufacturers breach that trust, a product liability lawsuit may result. Such is the case with Merck and Co., which found... Read more »

Mason v. Fresenius Medical Care Holdings, Inc. was filed directly into multidistrict litigation (MDL 2428) on December 10, 2014, joining thousands of similar claims that allege Granuflo and Naturalyte dialysis additives are defective and unreasonably dangerous. Plaintiff Robert Mason brought his product liability complaint individually and on behalf of the... Read more »

U.S. District Judge Matthew Kennelly has prescribed a case management plan and process for preparing bellwether trials in testosterone injury lawsuits not involving AbbVie’s AndroGel product, but rather the various testosterone treatments marketed and sold by several other manufacturers. Judge Kennelly’s order further clarifies a specific area of distinction among... Read more »

As Benicar lawsuits continue to escalate across the nation, plaintiffs have petitioned the Judicial Panel on Multidistrict Litigation (JPML) to consolidate similar actions that allege severe gastrointestinal injuries. In a motion filed on December 18, plaintiff Annette Johnson asked the JPML to transfer all federally-filed cases to the Northern District... Read more »

Over the past several years, the highly-anticipated next-generation blood thinner Xarelto has transformed from an exciting new addition to the American drug market to a potentially dangerous, even life-threatening treatment. Xarelto, which was designed and manufactured by Bayer and Johnson & Johnson subsidiary Janssen, has been named in 21 federal... Read more »

U.S. District Judge David R. Herndon ─ who is overseeing all federal Yaz and Yasmin lawsuits ─ has identified 33 cases for early bellwether trials that will likely beginning during the middle of 2015. All product liability lawsuits regarding the birth control pills have been joined together under multidistrict litigation... Read more »

New research published in the Canadian Journal of Cardiology suggests that Pradaxa and Xarelto bleeding risks may be no different than those of Warfarin (Coumadin). The study – conducted at Southlake Regional Health Centre in Ontario– examined 901 patients who took Warfarin and newer anticoagulants Pradaxa and Xarelto. After looking... Read more »

The powerful prescription medication Risperdal, which is classified as an “atypical antipsychotic,” was recently implicated in a federal personal injury lawsuit filed in United States District Court for the Middle District of Louisiana. At the heart of the plaintiff’s complaint is the assertion that her minor child was wrongfully exposed... Read more »